CORT Corcept Therapeutics Incorporated
$119.57 -2.02%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-2.02%
YTD
+32.40%
P/E
228.54
P/B
11.4
ROE
8.4%
Div yield
—
Beta
1.85
Market cap
$12.6B
RSI (14)
57
Next earnings
Nov 2, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$122.20
Close
$119.57
VWAP (n/a)
—
Day high
$122.54
Day low
$115.11
Volume
790K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Corcept, IBD Stock Of The Day, Setting Up Amid Booming Earnings Growth
Yahoo Finance · Oct 6
Strong Commercial Execution and Pipeline Opportunities Propel Corcept Therapeutics (CORT)
Yahoo Finance · Sep 25
Corcept Announces Planned Leadership Transition
Yahoo Finance · Sep 23
Corcept Therapeutics (CORT) CHMP Backing Keeps Undervalued Narrative In Focus
Yahoo Finance · Sep 22
Corcept’s (CORT) Cancer Drug Just Cleared Europe’s Toughest Hurdle
Yahoo Finance · Sep 22
Will Korlym Continue to Aid CORT's Growth Through the Rest of 2026?
Yahoo Finance · Sep 16
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Sep 23, 2026 View → 10-Q Jul 29, 2026 View → 8-K Jul 29, 2026 View → 8-K Jun 17, 2026 View → 8-K Jun 3, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell CORT. Try it in the Lab to size a position and see the risk.